{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:35:25Z","timestamp":1790789725753,"version":"4.1.0"},"reference-count":122,"publisher":"Informa UK Limited","issue":"7","funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["A-PARADDISE\/602080"],"award-info":[{"award-number":["A-PARADDISE\/602080"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FP7 Projects BLUEPRINT\/282510"],"award-info":[{"award-number":["FP7 Projects BLUEPRINT\/282510"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["IIT-Sapienza Project"],"award-info":[{"award-number":["IIT-Sapienza Project"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["Sapienza Ateneo Project 2014"],"award-info":[{"award-number":["Sapienza Ateneo Project 2014"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2017,7,3]]},"DOI":"10.1080\/13543776.2017.1316976","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T13:08:10Z","timestamp":1491829690000},"page":"797-813","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":45,"title":["EZH2 inhibitors: a patent review (2014-2016)"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-0850","authenticated-orcid":false,"given":"Giulia","family":"Stazi","sequence":"first","affiliation":[{"name":"Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universit\u00e0 di Roma, Rome, Italy"},{"name":"Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza Universit\u00e0 di Roma, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-0003","authenticated-orcid":false,"given":"Clemens","family":"Zwergel","sequence":"additional","affiliation":[{"name":"Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universit\u00e0 di Roma, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-2382","authenticated-orcid":false,"given":"Antonello","family":"Mai","sequence":"additional","affiliation":[{"name":"Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universit\u00e0 di Roma, Rome, Italy"},{"name":"Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza Universit\u00e0 di Roma, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-607X","authenticated-orcid":false,"given":"Sergio","family":"Valente","sequence":"additional","affiliation":[{"name":"Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universit\u00e0 di Roma, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/276565a0"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2007.08.006"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1242\/dev.033902"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2763"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076997"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/nature09784"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.11.004"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.06.020"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.16.6857-6868.2005"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600402"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/nature06145"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707292104"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1126\/science.1149042"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1038\/nature06192"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.019"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4036"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2004.02.001"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.02.043"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg542"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1299305"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.333"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.10.035"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1396-3"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.327"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1101\/gad.864201"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06148-11"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27859"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2011.02.012"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06315-11"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.454280"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.551"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2156"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1038\/nature01075"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1933744100"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.5180"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.08.002"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1623"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.09.055"},{"issue":"51","key":"CIT0039","doi-asserted-by":"crossref","first-page":"84453","DOI":"10.18632\/oncotarget.11497","volume":"7","author":"Cardenas H","year":"2016","journal-title":"Oncotarget"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504226102"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1247\/csf.06016"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90321-2"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5427"},{"issue":"6","key":"CIT0044","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.18632\/oncotarget.14378","volume":"8","author":"Alzrigat M","year":"2017","journal-title":"Oncotarget"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1038\/ng.518"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116418109"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012525107"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1038\/nature04733"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.12.043"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.2217\/fon.10.157"},{"key":"CIT0051","first-page":"172","volume":"7","author":"Karantanos T","year":"2016","journal-title":"Front Immunol"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1241904"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2008-0121"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02439"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002530107"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012479"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.08.013"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1742509"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69468"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2139"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.199612"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000031107"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.4155\/ppa.15.16"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90774-4"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0013"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1524107"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.06.021"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1084"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0223-4"},{"issue":"22","key":"CIT0070","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1182\/blood.V128.22.4203.4203","volume":"128","author":"Yap TA","year":"2016","journal-title":"Blood"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1021\/ml3003346"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210371110"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1021\/cb400133j"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303800110"},{"key":"CIT0075","unstructured":"Kuntz KW, Campbell JE, inventors; Epizyme, Inc., USA. assignee. Preparation of 1,4-pyridone compounds and useful in the treatment of cancer patent WO2014100646A1. 2014."},{"key":"CIT0076","unstructured":"Kuntz KW, Choi H-W, Mathieu S, et al. inventors; Epizyme, Inc., USA; Eisai R&D Management Co., Ltd. assignee. Preparation of N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4\u2019-(morpholinomethyl)-[1,1\u2019-biphenyl]-3-carboxamide monohydrochloride polymorph as an EZH2 inhibitor for cancer treatment patent WO2015057859A1. 2015."},{"key":"CIT0077","unstructured":"Keilhack H, Truitt B, Suzuki Y, et al. inventors; Epizyme, Inc., USA; Eisai R&D Management Co., Ltd. assignee. Method for treating cancer using histone methyltransferase EZH2 inhibitors patent WO2016081523A1. 2016."},{"issue":"23","key":"CIT0078","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V126.23.473.473","volume":"126","author":"Ribrag V","year":"2015","journal-title":"Blood"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1021\/ml400494b"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2015.06.056"},{"issue":"21","key":"CIT0081","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1021\/acs.jmedchem.6b01315","volume":"59","author":"Vaswani RG","year":"2016","journal-title":"J Med Chem"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5b00037"},{"key":"CIT0083","unstructured":"Kuntz KW, Campbell JE, Seki M, inventors; Epizyme, Inc., USA. assignee. Preparation of substituted benzene compounds as anticancer agents patent US20140107122A1. 2014."},{"key":"CIT0084","unstructured":"Campbell JE, Kuntz KW, inventors; Epizyme, Inc., USA. assignee. Preparation of substituted 6,5-fused bicyclic heteroaryl compounds as anticancer agents EZH2-mediated cancers patent WO2014144747A1. 2014."},{"key":"CIT0085","unstructured":"Campbell JE, inventor Epizyme, Inc., USA. assignee. Substituted 6,5-fused bicyclic heteroaryl compounds patent WO2015010078A2. 2015."},{"key":"CIT0086","unstructured":"Campbell JE, inventor Epizyme, Inc., USA. assignee. Preparation of substituted benzene compounds for treating cancer patent WO2015010049A1. 2015."},{"key":"CIT0087","unstructured":"Campbell JE, inventor Epizyme, Inc., USA. assignee. Substituted benzene and 6,5-fused bicyclic heteroaryl compounds patent WO2015200650A1. 2015."},{"key":"CIT0088","unstructured":"Miller WH, Romeril SP, Verma SK, et al. inventors; GlaxoSmithKline Intellectual Property No.2 Limited, UK. assignee. Preparation of pyridoazacyclotridecinoindole compounds as enhancer of zeste homolog 2 inhibitors for treating cancer patent WO2015132765A1. 2015."},{"key":"CIT0089","unstructured":"Burgess JL, Knight SD, inventors; GlaxoSmithKline Intellectual Property No.2 Limited, UK. assignee. Preparation of thiophenecarboxamide derivatives as enhancer of zeste homolog 2 inhibitors for the treatment of cancer patent WO2015004618A1. 2015."},{"key":"CIT0090","unstructured":"Knight SD, Newlander KA, Tian X, inventors; GlaxoSmithKline Intellectual Property No.2 Limited, UK. assignee. Preparation of N-oxopyridinylmethyl thiophenecarboxamides as enhancer of zeste homolog 2 inhibitors patent WO2016066697A1. 2016."},{"key":"CIT0091","unstructured":"Albrecht BK, Audia JE, Cook AS, et al. inventors; Constellation Pharmaceuticals, Inc., USA. assignee. Preparation of methyloxodihydropyridinylmethylcarbamoylmethylindole derivatives and analogs for use as histone methyl modifying enzyme modulators patent WO2014124418A1. 2014."},{"key":"CIT0092","unstructured":"Albrecht BK, Audia JE, Dakin LA, et al. inventors; Constellation Pharmaceuticals, Inc., USA. assignee. Preparation of indole derivatives as modulators of methyl modifying enzymes patent WO2015023915A1. 2015."},{"key":"CIT0093","unstructured":"Albrecht BK, Gehling VC, Harmange J-C, et al. inventors; Constellation Pharmaceuticals, Inc., USA. assignee. Preparation of substituted indolecarboxamides as modulators of methyl modifying enzymes patent WO2016130396A1. 2016."},{"key":"CIT0094","unstructured":"Kim KS, Zhang L, Purandare AV, et al. inventors; Bristol-Myers Squibb Company, USA. assignee. Preparation of substituted dihydroisoquinolines as inhibitors of histone-lysine N-methyltransferase patent WO2015077193A1. 2015."},{"key":"CIT0095","unstructured":"Seitz SP, Markwalder JA, Purandare AV, inventors; Bristol-Myers Squibb Company, USA. assignee. Preparation of N-((2-oxo-1,2-dihydropyridin-3-yl)methyl) amides as inhibitors of lysine methyl transferase patent WO2015077194A1. 2015."},{"key":"CIT0096","unstructured":"Kumpf RA, Kung -P-P, Sutton SC, et al. inventors; Pfizer Inc., USA. assignee. Preparation of aryl fused lactams as EZH2 modulators patent WO2015193768A1. 2015."},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00515"},{"key":"CIT0098","unstructured":"Collins MR, Kania RS, Kumpf RA, et al. inventors; Pfizer Inc., USA. assignee. Substituted dihydroisoquinolinone compounds as EZH2 inhibitors and their preparation patent US20150361067A1. 2015."},{"key":"CIT0099","unstructured":"Bradner JE, Qi J, Wong KK, inventors; Dana-Farber Cancer Institute, Inc., USA. assignee. EZH2 inhibitors and uses thereof patent WO2016073956A1. 2016."},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0164"},{"key":"CIT0101","unstructured":"Bradner JE, Blazar B, Flynn R, et al. inventors; Dana-Farber Cancer Institute, Inc., USA; Regents of the University of Minnesota. assignee. Use of compositions modulating chromatin structure for graft versus host disease patent WO2016073903A1. 2016."},{"key":"CIT0102","unstructured":"Fernandez-Montalvan A, Stresemann C, Christ C, et al. inventors; Bayer Pharma Aktiengesellschaft, Germany; The Broad Institute Inc. assignee. Imidazopyridine as EZH2 inhibitors and their preparation patent WO2016102493A1. 2016."},{"key":"CIT0103","unstructured":"Guo D, Yu K-L, inventors; Eli Lilly and Company, USA. assignee. Preparation of N-[(4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[(1R)-1-[trans-4-(3-methoxyazetidin-1-yl)cyclohexyl]ethyl]-4-methylthiophene-3-carboxamide and its isomer as inhibitors of EXH2 patent WO2016089804A1. 2016."},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11384"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00855"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.114"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3124"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.08.014"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2015.10.016"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0271-9"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111840"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3077"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1331"},{"key":"CIT0114","unstructured":"Walensky LD, inventor Dana-Farber Cancer Institute, Inc., USA. assignee. Stabilized EZH2 peptides for treatment of cancer patent WO2014151369A2. 2014."},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1021\/jm501230c"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3790"},{"issue":"1","key":"CIT0117","doi-asserted-by":"crossref","first-page":"e0169855","DOI":"10.1371\/journal.pone.0169855","volume":"12","author":"Li L","year":"2017","journal-title":"PLoS One"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01473"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01576"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2306"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2304"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-581082"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2017.1316976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T08:03:32Z","timestamp":1599293012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2017.1316976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":122,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7,3]]}},"alternative-id":["10.1080\/13543776.2017.1316976"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2017.1316976","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}